Procurement of biosamples for collection of primary tumors, metastatic lesions and normal tissue and residential history from greek subjects for genome-wide methylation analysis

Ended Purchase Order Awarded Last action

Contract number
HHSN261201700069A
Awardee
Awarding agency
Obligated
$24,900

Award facts

Opportunity
Contract value 100% obligated
$24,900.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
621511 Medical Laboratories
PSC
Q515 Medical- Pathology
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Greece

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The National Cancer Institute awarded a purchase order to National And Kapodistrian University Of Athens for $24,900.00 on September 12, 2017, for procurement of biosamples including primary tumors, metastatic lesions, normal tissue, and residential history from Greek subjects for genome-wide methylation analysis. Place of performance is Greece. The order carries no set-aside designation. Ultimate completion date is September 11, 2018. Pricing is firm fixed price.

Quick answers

Who was awarded contract HHSN261201700069A?

HHSN261201700069A was awarded to National And Kapodistrian University Of Athens by National Cancer Institute (National Institutes of Health) on September 12, 2017.

How much is contract HHSN261201700069A worth?

The government has obligated $24,900 on HHSN261201700069A.

Was contract HHSN261201700069A competed?

The extent of competition for HHSN261201700069A was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login